University of Birmingham researchers develop rapid COVID-19 RNA test
Test can give accurate results in under five minutes, according to researchers
6th January 2021
Latest news
Angelini Pharma acquires CNS specialist Arvelle Therapeutics
Key focus of the deal is focal-onset seizure treatment cenobamate
5th January 2021
EMA launches review of BMS’ Opdivo for oesophageal cancer
Company is aiming for approval in the adjuvant setting
5th January 2021
AstraZeneca completes Atacand divestment to Cheplapharm
The total value of all payments for the Atacand brand is $400m
5th January 2021
NICE collaboration creates new route for medicines approval
New Innovative Licensing and Access Pathway launched
5th January 2021
Pfizer’s Lorbrena scores US priority review
Drug is being reviewed for ALK-positive lung cancer
4th January 2021
CRUK scientists develop drug that targets KRAS pathways
KRAS mutations are found in several hard-to-treat cancers
4th January 2021
Janssen files EGFR-targeting antibody amivantamab with EMA
Submission based on results from phase I CHRYSALIS study
4th January 2021
AstraZeneca/Oxford University's COVID-19 vaccine set for UK rollout
Shot was approved by MHRA on 30 December
4th January 2021
Ridgeback Biotherapeutics’ Ebola treatment scores FDA approval
Ebanga approved to treat Ebola in adult and paediatric patients
24th December 2020
Amgen files KRAS inhibitor sotorasib with EMA
Submission supported by results from phase II CodeBreaK 100 study
24th December 2020
AMO Pharma launches late-stage study of CMD candidate
REACH-CDM study was based on results of positive phase II data
24th December 2020
Vicore Pharma’s C21 med shows promise in COVID-19 study
Drug is being studied in hospitalised COVID-19 patients
23rd December 2020
EU green light for Zogenix’s Fintepla
Oral solution approved to treat seizures associated with Dravet syndrome
23rd December 2020
Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model
Payment for drug linked to value to NHS rather than volume used
23rd December 2020
